Strategic business report on pharmaceutical grade silica gel

Dublin, December 5, 2024 (GLOBE NEWSWIRE) — The “Pharmaceutical Grade Silica Gel – Global Strategic Business Report” has been supplemented ResearchAndMarkets.com Offer.

The global pharmaceutical grade silica gel market was valued at $104.2 million in 2023 and is expected to reach $184.5 million by 2030, growing at a CAGR of 8.5% from 2023 to 2030.

What are the emerging trends in the pharmaceutical grade silica gel market?

Several trends are emerging in the pharmaceutical grade silica gel market as the industry continues to adapt to the changing needs of the pharmaceutical sector. A key trend is the increasing emphasis on sustainability and environmentally friendly manufacturing processes. As pharmaceutical companies face increasing pressure to reduce their environmental footprint, demand for environmentally friendly desiccant solutions, including silica gel, is increasing. Manufacturers are focusing on reducing waste and energy consumption in the production of silica gel, as well as developing biodegradable silica-based products that meet environmental standards.

Another important trend is the increasing use of pharmaceutical-grade silica gel in biopharmaceuticals and biologics. Since these drug formulations are often very sensitive to moisture, silica gel is an indispensable component in packaging and storage. As the market for biologics and biosimilars continues to grow, so does the demand for high-quality, pharmaceutical-grade silica gel that can ensure the stability of these complex therapies. Additionally, the rise of personalized medicine and targeted drug delivery is expected to drive further innovation in silica gel formulations as tailored drug delivery systems require precise moisture control and protection.

The market for pharmaceutical-grade silica gel is also characterized by official controls. Stricter drug safety and quality control guidelines are driving manufacturers to ensure their silica gel products meet strict standards. The need for pharmaceutical companies to comply with global regulations such as Good Manufacturing Practices (GMP) and guidelines from the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) has increased the demand for high-purity, pharmaceutical-grade desiccants. Additionally, the rise of smart packaging solutions that combine silica gel with digital sensors to monitor moisture levels in real-time is an emerging trend that could revolutionize drug packaging in the future.

What is driving the growth in the pharmaceutical grade silica gel market?

The growth of the pharmaceutical grade silica gel market is driven by several key factors, including increasing demand for moisture control in drug formulations, advancements in drug development technologies, and increasing regulatory pressure on pharmaceutical companies. One of the most important growth drivers is the expansion of the global pharmaceutical industry, particularly in emerging markets. As more pharmaceutical products are developed and distributed worldwide, the need for effective packaging solutions to protect these products from moisture and other environmental factors becomes increasingly important. This has led to an increase in demand for pharmaceutical-grade silica gel, particularly in regions such as Asia Pacific where pharmaceutical production is growing rapidly.

Another important factor is the increased production of biologics and biosimilars, which require precise moisture control to maintain their stability and effectiveness. Biopharmaceuticals are more sensitive to environmental conditions than traditional small molecule drugs, making high-quality desiccants such as pharmaceutical-grade silica gel essential for their storage and transportation. As the biologics market continues to grow due to advances in personalized medicine and novel therapies, demand for silica gel is expected to increase accordingly.

Technological innovations in drug delivery systems and packaging are also contributing to the growth of the market. The development of advanced drug formulations that require specific moisture content has increased the use of silica gel in packaging solutions. Additionally, innovations such as smart packaging technologies that combine moisture control with digital monitoring tools are creating new opportunities for pharmaceutical-grade silica gel manufacturers. Additionally, the shift towards sustainable and eco-friendly packaging is increasing the demand for biodegradable and eco-friendly silica gel products as pharmaceutical companies seek to reduce their environmental impact. Finally, increasing focus on regulatory compliance and quality control is driving the demand for high-purity silica gel products that meet global pharmaceutical standards. As regulatory authorities impose stricter guidelines on the storage and transportation of pharmaceutical products, companies are increasingly turning to powerful desiccants such as pharmaceutical-grade silica gel to ensure their products meet required safety and quality standards. These factors, along with the continued expansion of the pharmaceutical industry, are expected to drive sustained growth in the pharmaceutical grade silica gel market.

Key Takeaways:

• Market Growth: Understand the significant growth trajectory of the desiccant applications segment, which is expected to reach $81 million by 2030, at a compound annual growth rate of 8.4%. The Drug Carrier Application segment is also expected to grow at a CAGR of 10.5% during the analysis period.
• Regional Analysis: Gain insight into the US market, estimated at US$28.7 million in 2023, and China, which will see impressive 7.9% annual growth to US$28.3 million by 2030. Dollar is forecast. Discover growth trends in other key regions including Japan, Canada, Germany, and Asia Pacific.

Key questions answered:

• How is the global pharmaceutical grade silica gel market expected to develop by 2030?
• What are the key drivers and restraints affecting the market?
• Which market segments will grow the most during the forecast period?
• How will the market shares of different regions and segments change by 2030?
• Who are the leading players in the market and what are their prospects?

Reporting features:

• Comprehensive market data: Independent analysis of annual sales and market forecasts in millions of US dollars from 2023 to 2030.
• Detailed Regional Analysis: Detailed insights into key markets including the US, China, Japan, Canada, Europe, Asia Pacific, Latin America, the Middle East and Africa.
• Company Profiles: Coverage of key players in the global pharmaceutical grade silica gel market such as Clariant International Ltd., Desiccare, Inc., DuPont, EI du Pont de Nemours and Company, Evonik Industries and more.
• Free Updates: Receive one year of free report updates to keep you up to date on the latest market developments.

The 42 companies featured in this global pharmaceutical grade silica gel market report include:

• Clariant International Ltd.
• Desiccare, Inc.
• DuPont
• EI du Pont de Nemours and company
• Evonik Industries
• Fuji Silysia Chemical
• Interra Global Corp.
• Merck
• Multisorb Technologies, Inc.
• Solvay SA
• Sorbead India
• The Dow Chemical Company
• WR Grace and company

Key attributes:

Main topics covered:

MARKET OVERVIEW

• World market trends
• Global economic update
• Pharmaceutical Grade Silica Gel – Percentage Market Share of Key Global Competitors in 2024 (E)
• Competitive market presence – strong/active/niche/trivial for players worldwide in 2024 (E)

Market trends and drivers

• The increasing use of pharmaceutical-grade silica gel as a desiccant in pharmaceutical packaging is driving market growth for moisture control solutions
• Increasing demand for silica gel to stabilize and protect pharmaceutical ingredients and finished products
• The expansion of biopharmaceuticals and highly sensitive drugs strengthens the demand for high-quality silica gel as an adsorbent in drug formulations
• Technological advances in silica gel manufacturing processes are improving the level of purity and suitability for pharmaceutical applications
• The growing focus on regulatory compliance and cGMP standards in pharmaceutical packaging is driving demand for certified pharmaceutical grade silica gel
• The increasing use of silica gel in drug delivery systems, including solid dosage forms, is expanding its scope in the pharmaceutical industry
• Increasing focus on moisture control in injectable medications and vaccines is driving demand for pharmaceutical-grade silica gel in sterile packaging
• Increasing use of silica gel in chromatographic separation processes for purification and isolation of active pharmaceutical ingredients (APIs)
• New use of silica gel as a carrier for controlled drug release in specialized pharmaceutical formulations
• Increasing demand for pharmaceutical grade silica gel in the production of extended and delayed release drugs
• Technological innovations in fine-mesh and pore-controlled silica gel improve its adsorption capacity and effectiveness in pharmaceutical applications
• Growing interest in environmentally friendly and biodegradable desiccant solutions is expanding the market for sustainable, pharmaceutical-grade silica gel

Focus on selected players

• Clariant International Ltd.
• Desiccare, Inc.
• DuPont
• EI du Pont de Nemours and company
• Evonik Industries
• Fuji Silysia Chemical
• Interra Global Corp.
• Merck
• Multisorb Technologies, Inc.
• Solvay SA
• Sorbead India
• The Dow Chemical Company
• WR Grace and CompanyFor more information about this report, please visit https://www.researchandmarkets.com/r/beycdg

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source of international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

• Pharmaceutical grade silica gel market